Evidence map›Paper›PMID 27744605›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Uncommonly isolated clinical Pseudomonas: identification and phylogenetic assignation.

M Mulet, M Gomila, A Ramírez, S Cardew, E R B Moore, J Lalucat, E García-Valdés

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Comparative genomics ofFrontiers in microbiology · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. The first report ofClinical case reports · 2019
    Article
  8. High-quality draft genome sequences ofAccess microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M MuletDepartment of Biology, Microbiology, Edificio Guillem Colom, Universitat de les Illes Balears, Crtra.Valldemossa km 7.5, 07122, Palma de Mallorca, Spain.
M GomilaDepartment of Biology, Microbiology, Edificio Guillem Colom, Universitat de les Illes Balears, Crtra.Valldemossa km 7.5, 07122, Palma de Mallorca, Spain.
A RamírezServicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
S CardewDepartment of Infectious Disease, Institute of Biomedicine, Sahlgrenska Academy of the University of Gothenburg, Gothenburg, Sweden.
E R B MooreDepartment of Infectious Disease, Institute of Biomedicine, Sahlgrenska Academy of the University of Gothenburg, Gothenburg, Sweden.
J LalucatDepartment of Biology, Microbiology, Edificio Guillem Colom, Universitat de les Illes Balears, Crtra.Valldemossa km 7.5, 07122, Palma de Mallorca, Spain.
E García-ValdésDepartment of Biology, Microbiology, Edificio Guillem Colom, Universitat de les Illes Balears, Crtra.Valldemossa km 7.5, 07122, Palma de Mallorca, Spain. elena.garciavaldes@uib.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fifty-two Pseudomonas strains that were difficult to identify at the species level in the phenotypic routine characterizations employed by clinical microbiology laboratories were selected for genotypic-based analysis. Species level identifications were done initially by partial sequencing of the DNA dependent RNA polymerase sub-unit D gene (rpoD). Two other gene sequences, for the small sub-unit ribosonal RNA (16S rRNA) and for DNA gyrase sub-unit B (gyrB) were added in a multilocus sequence analysis (MLSA) study to confirm the species identifications. These sequences were analyzed with a collection of reference sequences from the type strains of 161 Pseudomonas species within an in-house multi-locus sequence analysis database. Whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analyses of these strains complemented the DNA sequenced-based phylogenetic analyses and were observed to be in accordance with the results of the sequence data. Twenty-three out of 52 strains were assigned to 12 recognized species not commonly detected in clinical specimens and 29 (56 %) were considered representatives of at least ten putative new species. Most strains were distributed within the P. fluorescens and P. aeruginosa lineages. The value of rpoD sequences in species-level identifications for Pseudomonas is emphasized. The correct species identifications of clinical strains is essential for establishing the intrinsic antibiotic resistance patterns and improved treatment plans.

Indexed as

PhylogenyCluster AnalysisDNA, BacterialDNA-Directed RNA PolymerasesDNA GyraseDNA, RibosomalGenotypeHumansMultilocus Sequence TypingPhenotypePseudomonasPseudomonas InfectionsRNA, Ribosomal, 16SSequence Analysis, DNASpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationDNA, BacterialDNA-Directed RNA PolymerasesDNA GyraseDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.